TOSO, also known as Fas-inhibitory molecule 3 (FAIM3) or Fc mu receptor (FCMR) in humans is encoded by the FCMR gene. FCMR
was defined as a 60-kD transmembrane sialoglycoprotein and FCMR (TOSO) expression was up-regulated on B cells, but was down-modulated on T cells, suggesting differential regulation of TOSO expression during B and T cell activation. Human FCMR mRNA was strongly
expressed in hematopoietic tissues such as the spleen, thymus and peripheral blood leukocytes. Intracellular upregulation of Fc mu receptor (FCMR, FAIM3/TOSO) gene in the leukemic lymphocytes of the patients with CLL may be an important parameter in predicting the progression of the disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | Inquiry & Datasheet |
CAR-LC125 | Anti-TOSO (6B10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 6B10 | Rat | scFv-CD28-CD3ζ | Retroviral | T cell |
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MOREAngiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.
LEARN MORETRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MOREThe latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE